Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Gynecologic 1CNS 1

Conditions

Prostatic Neoplasms 9Wilms Tumor 2Pancreatic Neoplasms 2Kidney Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hepatic Veno-Occlusive Disease 1Genetic Predisposition to Disease 1Colorectal Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

pembrolizumab 23Gemcitabine 14Carboplatin 10Nivolumab 9Cyclophosphamide 9olaparib 8Specimen Handling 8Paclitaxel 8Trastuzumab 7Magnetic Resonance Spectroscopy 6fludarabine 5Standard of Care 5Irinotecan 5Ipilimumab 5Docetaxel 5Cisplatin 5Capecitabine 5Biopsy 5sargramostim 4pertuzumab 4palbociclib 4enzalutamide 4durvalumab 4atezolizumab 4aldesleukin 4Taxes 4Oxaliplatin 4Fluorouracil 4Erlotinib Hydrochloride 4Early Intervention, Educational 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Genetic Testing × Genitourinary × Clear all
NCT03934606 2025-04-10

Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

Abramson Cancer Center at Penn Medicine

Completed
1,488 enrolled
GastrointestinalGenitourinary

Pancreatic Neoplasms, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
197 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡